Gastrointestinal (GI) cancer refers to tumours of the oesophagus, pancreas, stomach, colon, rectum, anus, liver, biliary system, and small intestine that affect the gastrointestinal tract and other organs located within the digestive system. When the cells lining one or more of the organs in the digestive tract change and begin to grow, tumours form, and the cancer can spread to the lymph nodes and other organs. Patients with early-stage GI cancer may not experience any symptoms. It's also practically hard to feel gastrointestinal tumours as they grow. As a result, GI malignancies are frequently detected in screenings prior to the onset of symptoms. Or they're diagnosed after they've progressed to the point where they're producing more serious symptoms.
Hepatocellular carcinoma (HCC) is a type of cancer that begins in the liver. It's not the same as "secondary" liver tumours, which have moved from other organs to the liver. It can sometimes be treated with surgery or transplantation if discovered early. Although it cannot be cured in more severe cases, treatment and care can help the patient live longer and better.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Complex endoscopy in pediatrics: Optimizing care
Monique Barakat, Stanford University School of Medicine, United States
Title : Use of indocyanine green fluorescence imaging in the extrahepatic biliary tract surgery
Orestis Ioannidis, Aristotle University of Thessaloniki, Greece
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States
Title : Efficacy of sertraline on the symptoms and quality of life in patients with irritable bowel syndrome: A single-blinded and parallel designed randomized controlled trial
Sara Seifouri, St. Thomas NHS Foundation Trust, United Kingdom